The UK heated tobacco market continues to evolve rapidly, with growing consumer interest and an increasingly competitive landscape.

Understanding potentially harmful chemicals and the toxicological impact of your nicotine product is essential for marketing authorization. We provide accredited, accurate, and flexible testing for all stages of product development, regulatory submission, and post-launch support.
Harmful and Potentially Harmful Constituents (HPHCs) are one of the critical quality attributes of next generation nicotine delivery products. Understanding and controlling these constituents is vital in developing, launching, and maintaining your NGP on the market. As a manufacturer, you must understand the potential risks of your NGPs and ensure they comply with regulatory standards and safety guidance.
The determination of HPHCs is a critical factor in assessing the potential health benefits of NGPs relative to the known risks of smoking combustible cigarettes and are a mandatory requirement for regulatory pathways such as Premarket Tobacco Product Application (PMTA) submissions.
Our HPHC testing service covers the following NGP product categories.
With over 15 years of experience working with global NGP manufacturers, we have extensive experience providing HPHC analytical testing for a wide range of NGP product categories. We have developed and validated robust and highly sensitive analytical methods and operate within ISO17025 and GMP accredited laboratory environments appropriate for whichever regulatory pathway you wish to follow. Our scientists deliver high-quality HPHC data with industry-leading turnaround times.
Work with an HPHC analytical testing partner that guarantees accuracy at high levels of sensitivity and selectivity through techniques such as ICP-MS, LC-MS/MS, GC-MS to ensure complete characterization of your product.
We offer the full suite of HPHC testing as specified in international guidelines and directives, including the U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and the Medicines and Healthcare products Regulatory Agency (MHRA).
Other non-routine HPHC methods are available upon request as well as a highly-skilled method development to test none routine analytes.
Our scientists are highly skilled in developing and validating analytical methods to meet global regulatory requirements. We have extensive experience working across a wide range of NGP products for the determination of the core HPHCs listed by global regulatory authorities and can rapidly develop bespoke methods to assess HPHCs for individual product designs.
Benefit from the added reassurance of access to a fully integrated service team across analytical testing and scientific consultancy. When potential risk areas or unexpected results are uncovered, our highly experienced scientific consultants are on-hand to help analyze test data and troubleshoot with your in-house team.
All methodology for U.S. regulatory submissions, and the associated validation documents, are maintained within a Tobacco Product Master File (TPMF) that has been reviewed by FDA in support of products that have been granted marketing orders under the PMTA pathway.
Our document management complies with United Kingdom Accreditation Service (UKAS) ISO/IEC 17025:2017, FDA 21 CFR Part 820, and International Conference on Harmonization ICH (Q2)R1 requirements.
Learn more about how we can help bring your nicotine delivery product to market through our high-quality analytical testing services.
At Broughton, our consultants have deep industry knowledge across all the elements required for a PMTA. We guide you through and generate the required data, to ensure that FDA finds your applications strong and compelling.
Learn more about our activities and gain insight from our scientific and regulatory experts
2 minute read
The UK heated tobacco market continues to evolve rapidly, with growing consumer interest and an increasingly competitive landscape.
2 minute read
The Ministry of Industry and Advanced Technology (MoIAT) has recently issued the Final Draft Standard (FDS) UAE.
1 minute read
The nicotine pouch market in the US is growing rapidly, but so is regulatory scrutiny.